Voya Investment Management LLC Avidity Biosciences, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 332,983 shares of RNA stock, worth $10.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

332,983

Previous 224,503 48.32%

Holding current value

$10.6 Million

Previous $9.17 Million 66.77%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$37.21 - $48.14 $4.04 Million - $5.22 Million	108,480 Added 48.32%	332,983 $15.3 Million
Q2 2024 Dec 03, 2024	SELL	$22.73 - $40.85 $2.47 Million - $4.43 Million	-108,480 Reduced 32.58%	224,503 $9.17 Million
Q2 2024 Aug 14, 2024	BUY	$22.73 - $40.85 $4.55 Million - $8.17 Million	199,982 Added 815.55%	224,503 $9.17 Million
Q1 2024 Dec 06, 2024	SELL	$9.16 - $25.52 $2.83 Million - $7.87 Million	-308,462 Reduced 92.64%	24,521 $625,000
Q1 2024 May 15, 2024	SELL	$9.16 - $25.52 $43,619 - $121,526	-4,762 Reduced 16.26%	24,521 $625,000
Q4 2023 Feb 14, 2024	SELL	$4.87 - $9.37 $114,464 - $220,232	-23,504 Reduced 44.53%	29,283 $265,000
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $4,410 - $7,945	700 Added 1.34%	52,787 $336,000
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $37,531 - $61,279	3,534 Added 7.28%	52,087 $577,000
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $62,182 - $103,908	4,051 Added 9.1%	48,553 $745,000
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $250,151 - $563,463	24,866 Added 126.63%	44,502 $987,000
Q3 2022 Mar 03, 2023	SELL	$15.46 - $23.43 $384,428 - $582,610	-24,866 Reduced 55.88%	19,636 $320,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $16,573 - $25,116	1,072 Added 5.77%	19,636 $321,000
Q2 2022 Aug 15, 2022	BUY	$11.18 - $20.5 $42,215 - $77,408	3,776 Added 25.53%	18,564 $270,000
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $13,871 - $19,488	680 Added 4.82%	14,788 $352,000
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $24,552 - $34,083	1,352 Added 10.6%	14,108 $347,000
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $258,691 - $359,081	12,756 New	12,756 $278,000

Others Institutions Holding RNA

# of Institutions

255

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.66B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Avidity Biosciences, Inc. Transaction History